GAROFALO HEALTH CARE SPA (GHC.MI) Stock Fundamental Analysis
Europe - BIT:GHC - IT0005345233 - Common Stock
5.24 EUR
-0.06 (-1.13%)
Taking everything into account, GHC scores 4 out of 10 in our fundamental rating. GHC was compared to 27 industry peers in the Health Care Providers & Services industry. GHC has an average financial health and profitability rating. GHC has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year GHC was profitable.
In the past year GHC had a positive cash flow from operations.
Each year in the past 5 years GHC has been profitable.
In the past 5 years GHC always reported a positive cash flow from operatings.
1.2 Ratios
GHC has a better Return On Assets (3.66%) than 70.37% of its industry peers.
The Return On Equity of GHC (9.57%) is comparable to the rest of the industry.
The Return On Invested Capital of GHC (6.52%) is better than 66.67% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GHC is in line with the industry average of 5.99%.
The last Return On Invested Capital (6.52%) for GHC is above the 3 year average (4.41%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROIC | 6.52% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
1.3 Margins
GHC has a better Profit Margin (4.62%) than 74.07% of its industry peers.
GHC's Profit Margin has declined in the last couple of years.
GHC has a Operating Margin of 9.37%. This is amongst the best in the industry. GHC outperforms 81.48% of its industry peers.
In the last couple of years the Operating Margin of GHC has declined.
The Gross Margin of GHC (44.90%) is comparable to the rest of the industry.
GHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% |
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GHC is destroying value.
The number of shares outstanding for GHC remains at a similar level compared to 1 year ago.
The number of shares outstanding for GHC has been increased compared to 5 years ago.
GHC has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 1.95 indicates that GHC is not a great score, but indicates only limited risk for bankruptcy at the moment.
GHC has a Altman-Z score (1.95) which is comparable to the rest of the industry.
GHC has a debt to FCF ratio of 70.49. This is a negative value and a sign of low solvency as GHC would need 70.49 years to pay back of all of its debts.
GHC has a Debt to FCF ratio of 70.49. This is in the lower half of the industry: GHC underperforms 77.78% of its industry peers.
GHC has a Debt/Equity ratio of 0.67. This is a neutral value indicating GHC is somewhat dependend on debt financing.
GHC's Debt to Equity ratio of 0.67 is fine compared to the rest of the industry. GHC outperforms 74.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Altman-Z | 1.95 |
ROIC/WACC1
WACC6.53%
2.3 Liquidity
A Current Ratio of 1.16 indicates that GHC should not have too much problems paying its short term obligations.
GHC has a Current ratio of 1.16. This is in the better half of the industry: GHC outperforms 62.96% of its industry peers.
GHC has a Quick Ratio of 1.12. This is a normal value and indicates that GHC is financially healthy and should not expect problems in meeting its short term obligations.
GHC has a Quick ratio of 1.12. This is in the better half of the industry: GHC outperforms 77.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 |
3. Growth
3.1 Past
GHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.11%.
GHC shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.81% yearly.
GHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.44%.
GHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.92% yearly.
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
3.2 Future
GHC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.47% yearly.
The Revenue is expected to grow by 1.51% on average over the next years.
EPS Next Y3.45%
EPS Next 2Y6.67%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 14.56 indicates a correct valuation of GHC.
Based on the Price/Earnings ratio, GHC is valued a bit cheaper than 70.37% of the companies in the same industry.
GHC is valuated rather cheaply when we compare the Price/Earnings ratio to 26.10, which is the current average of the S&P500 Index.
GHC is valuated correctly with a Price/Forward Earnings ratio of 15.72.
GHC's Price/Forward Earnings is on the same level as the industry average.
The average S&P500 Price/Forward Earnings ratio is at 22.52. GHC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.56 | ||
| Fwd PE | 15.72 |
4.2 Price Multiples
GHC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. GHC is cheaper than 70.37% of the companies in the same industry.
GHC's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. GHC is more expensive than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 145.52 | ||
| EV/EBITDA | 7.33 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
GHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)4.22
PEG (5Y)1.65
EPS Next 2Y6.67%
EPS Next 3Y6.47%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.60%, GHC has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.53, GHC pays a bit more dividend than its industry peers.
GHC's Dividend Yield is slightly below the S&P500 average, which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.6% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y6.67%
EPS Next 3Y6.47%
BIT:GHC (10/31/2025, 5:19:53 PM)
5.24
-0.06 (-1.13%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners11.44%
Inst Owner ChangeN/A
Ins Owners62.9%
Ins Owner ChangeN/A
Market Cap472.65M
Revenue(TTM)690.85M
Net Income(TTM)31.91M
Analysts84
Price Target6.73 (28.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.6% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.56 | ||
| Fwd PE | 15.72 | ||
| P/S | 0.68 | ||
| P/FCF | 145.52 | ||
| P/OCF | 16.92 | ||
| P/B | 1.42 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.33 |
EPS(TTM)0.36
EY6.87%
EPS(NY)0.33
Fwd EY6.36%
FCF(TTM)0.04
FCFY0.69%
OCF(TTM)0.31
OCFY5.91%
SpS7.66
BVpS3.7
TBVpS-0.44
PEG (NY)4.22
PEG (5Y)1.65
Graham Number5.47
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.66% | ||
| ROE | 9.57% | ||
| ROCE | 9.13% | ||
| ROIC | 6.52% | ||
| ROICexc | 6.77% | ||
| ROICexgc | 14.86% | ||
| OM | 9.37% | ||
| PM (TTM) | 4.62% | ||
| GM | 44.9% | ||
| FCFM | 0.47% |
ROA(3y)2.83%
ROA(5y)2.81%
ROE(3y)7.12%
ROE(5y)6.88%
ROIC(3y)4.41%
ROIC(5y)3.91%
ROICexc(3y)4.63%
ROICexc(5y)4.13%
ROICexgc(3y)10.78%
ROICexgc(5y)9.37%
ROCE(3y)6.5%
ROCE(5y)5.8%
ROICexgc growth 3Y7.97%
ROICexgc growth 5Y2.8%
ROICexc growth 3Y6.71%
ROICexc growth 5Y0.74%
OM growth 3Y-0.19%
OM growth 5Y-3.37%
PM growth 3Y-11.52%
PM growth 5Y-7.03%
GM growth 3Y0.36%
GM growth 5Y-1.06%
F-Score5
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 70.49 | ||
| Debt/EBITDA | 2.47 | ||
| Cap/Depr | 94.13% | ||
| Cap/Sales | 3.57% | ||
| Interest Coverage | 6.62 | ||
| Cash Conversion | 30.7% | ||
| Profit Quality | 10.18% | ||
| Current Ratio | 1.16 | ||
| Quick Ratio | 1.12 | ||
| Altman-Z | 1.95 |
F-Score5
WACC6.53%
ROIC/WACC1
Cap/Depr(3y)82.25%
Cap/Depr(5y)102.09%
Cap/Sales(3y)4.73%
Cap/Sales(5y)5.79%
Profit Quality(3y)118.21%
Profit Quality(5y)101.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.11%
EPS 3Y5.52%
EPS 5Y8.81%
EPS Q2Q%2.71%
EPS Next Y3.45%
EPS Next 2Y6.67%
EPS Next 3Y6.47%
EPS Next 5YN/A
Revenue 1Y (TTM)10.44%
Revenue growth 3Y18.48%
Revenue growth 5Y18.92%
Sales Q2Q%3.08%
Revenue Next Year3.78%
Revenue Next 2Y4.6%
Revenue Next 3Y3.74%
Revenue Next 5Y1.51%
EBIT growth 1Y-8.88%
EBIT growth 3Y18.26%
EBIT growth 5Y14.91%
EBIT Next Year67.89%
EBIT Next 3Y22.98%
EBIT Next 5Y16.09%
FCF growth 1Y-88.34%
FCF growth 3Y4.79%
FCF growth 5Y6.69%
OCF growth 1Y-35.2%
OCF growth 3Y-1.23%
OCF growth 5Y13.09%
GAROFALO HEALTH CARE SPA / GHC.MI FAQ
Can you provide the ChartMill fundamental rating for GAROFALO HEALTH CARE SPA?
ChartMill assigns a fundamental rating of 4 / 10 to GHC.MI.
Can you provide the valuation status for GAROFALO HEALTH CARE SPA?
ChartMill assigns a valuation rating of 4 / 10 to GAROFALO HEALTH CARE SPA (GHC.MI). This can be considered as Fairly Valued.
Can you provide the profitability details for GAROFALO HEALTH CARE SPA?
GAROFALO HEALTH CARE SPA (GHC.MI) has a profitability rating of 6 / 10.
What are the PE and PB ratios of GAROFALO HEALTH CARE SPA (GHC.MI) stock?
The Price/Earnings (PE) ratio for GAROFALO HEALTH CARE SPA (GHC.MI) is 14.56 and the Price/Book (PB) ratio is 1.42.
How financially healthy is GAROFALO HEALTH CARE SPA?
The financial health rating of GAROFALO HEALTH CARE SPA (GHC.MI) is 4 / 10.